These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16183285)

  • 1. Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots.
    Tomlinson ID; Mason JN; Blakely RD; Rosenthal SJ
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5307-10. PubMed ID: 16183285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dots.
    Tomlinson ID; Warnerment MR; Mason JN; Vergne MJ; Hercules DM; Blakely RD; Rosenthal SJ
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5656-60. PubMed ID: 17766114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots.
    Tomlinson ID; Mason JN; Blakely RD; Rosenthal SJ
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4664-7. PubMed ID: 16784853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological affinity of new imidazo- and indol-arylpiperazine derivatives: further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists.
    Strappaghetti G; Mastrini L; Lucacchini A; Giannaccini G; Betti L; Fabbrini L
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5140-5. PubMed ID: 18760923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity studies of benzyl ester meperidine and normeperidine derivatives as selective serotonin transporter ligands.
    Gu X; Izenwasser S; Wade D; Housman A; Gulasey G; Rhoden JB; Savoie CD; Mobley DL; Lomenzo SA; Trudell ML
    Bioorg Med Chem; 2010 Dec; 18(23):8356-64. PubMed ID: 20980153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
    J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological screening of novel indolalkyl arenes targeting the serotonine transporter.
    Ojeda-Gómez C; Pessoa-Mahana H; Iturriaga-Vásquez P; Pessoa-Mahana CD; Recabarren-Gajardo G; Méndez-Rojas C
    Arch Pharm (Weinheim); 2014 Mar; 347(3):174-84. PubMed ID: 24339227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.
    Deskus JA; Epperson JR; Sloan CP; Cipollina JA; Dextraze P; Qian-Cutrone J; Gao Q; Ma B; Beno BR; Mattson GK; Molski TF; Krause RG; Taber MT; Lodge NJ; Mattson RJ
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3099-104. PubMed ID: 17391962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective synthesis of a highly potent selective serotonin reuptake inhibitor. An application of imidazolidinone catalysis to the alkylation of indoles with an alpha,beta-disubstituted alpha,beta-unsaturated aldehyde.
    King HD; Meng Z; Denhart D; Mattson R; Kimura R; Wu D; Gao Q; Macor JE
    Org Lett; 2005 Aug; 7(16):3437-40. PubMed ID: 16048311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.
    Mahaney PE; Kim CY; Coghlan RD; Cohn ST; Heffernan GD; Huselton CA; Terefenko EA; Vu AT; Zhang P; Burroughs KD; Cosmi SA; Bray JA; Johnston GH; Deecher DC; Trybulski EJ
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5807-10. PubMed ID: 19713106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally restricted homotryptamines. Part 6: indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.
    Ditta JL; Denhart DJ; Deskus JA; Epperson JR; Meng Z; Gao Q; Mattson GK; Lapaglia MA; Taber MT; Molski TF; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2013 May; 23(10):2948-50. PubMed ID: 23578689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines.
    Mahaney PE; Vu AT; McComas CC; Zhang P; Nogle LM; Watts WL; Sarkahian A; Leventhal L; Sullivan NR; Uveges AJ; Trybulski EJ
    Bioorg Med Chem; 2006 Dec; 14(24):8455-66. PubMed ID: 16973367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
    Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
    J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT
    Wróbel MZ; Chodkowski A; Marciniak M; Dawidowski M; Maksymiuk A; Siwek A; Nowak G; Turło J
    Bioorg Chem; 2020 Apr; 97():103662. PubMed ID: 32086055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor.
    Pessoa-Mahana H; González-Lira C; Fierro A; Zapata-Torres G; Pessoa-Mahana CD; Ortiz-Severin J; Iturriaga-Vásquez P; Reyes-Parada M; Silva-Matus P; Saitz-Barría C; Araya-Maturana R
    Bioorg Med Chem; 2013 Dec; 21(24):7604-11. PubMed ID: 24262884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.
    Staroń J; Pietruś W; Bugno R; Kurczab R; Satała G; Warszycki D; Lenda T; Wantuch A; Hogendorf AS; Hogendorf A; Duszyńska B; Bojarski AJ
    Eur J Med Chem; 2021 Aug; 220():113533. PubMed ID: 34049262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.
    Greiner E; Boos TL; Prisinzano TE; De Martino MG; Zeglis B; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
    J Med Chem; 2006 Mar; 49(5):1766-72. PubMed ID: 16509591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
    Nencetti S; Mazzoni MR; Ortore G; Lapucci A; Giuntini J; Orlandini E; Banti I; Nuti E; Lucacchini A; Giannaccini G; Rossello A
    Eur J Med Chem; 2011 Mar; 46(3):825-34. PubMed ID: 21272963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single molecule analysis of serotonin transporter regulation using antagonist-conjugated quantum dots reveals restricted, p38 MAPK-dependent mobilization underlying uptake activation.
    Chang JC; Tomlinson ID; Warnement MR; Ustione A; Carneiro AM; Piston DW; Blakely RD; Rosenthal SJ
    J Neurosci; 2012 Jun; 32(26):8919-29. PubMed ID: 22745492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.